Quote | Kronos Bio Inc. (NASDAQ:KRON)
Last: | $1.02 |
---|---|
Change Percent: | -1.85% |
Open: | $1 |
Close: | $1.02 |
High: | $1.04 |
Low: | $0.982 |
Volume: | 249,632 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Kronos Bio Inc. (NASDAQ:KRON)
2024-05-10 07:27:16 ET More on Kronos Bio Kronos Bio: Underestimated Drug Discovery Platform Kronos cuts 21% of workforce, extends cash runway into 2H 2026 Seeking Alpha’s Quant Rating on Kronos Bio Historical earnings data for Kronos Bio Finan...
— $152.0 million cash runway into the second half of 2026 — — A study update on KB-0742-1001 will be presented at the upcoming American Society of Clinical Oncology (ASCO); expansion cohorts at new dose schedule remain on track to open in Q3 2024 —...
Message Board Posts | Kronos Bio Inc. (NASDAQ:KRON)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Kronos Bio Inc. Company Name:
KRON Stock Symbol:
NASDAQ Market:
— $152.0 million cash runway into the second half of 2026 — — A study update on KB-0742-1001 will be presented at the upcoming American Society of Clinical Oncology (ASCO); expansion cohorts at new dose schedule remain on track to open in Q3 2024 —...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
SAN MATEO, Calif. and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (NASDAQ:KRON), a company dedicated to transforming t...